Page last updated: 2024-08-26

arsenic and selegiline

arsenic has been researched along with selegiline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SG; Lee, CH; Park, JW1

Other Studies

1 other study(ies) available for arsenic and selegiline

ArticleYear
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.
    Journal of toxicology and environmental health. Part A, 2004, Volume: 67, Issue:23-24

    Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured

2004